Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
The Laboratory of Genetics and Metabolism, |
RCV001647334 | SCV001737524 | pathogenic | Mowat-Wilson syndrome | 2021-03-06 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001647334 | SCV002243429 | pathogenic | Mowat-Wilson syndrome | 2021-02-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro906Leufs*24) in the ZEB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZEB2 are known to be pathogenic (PMID: 16053902). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with Mowat-Wilson sydrome (PMID: 27831545). This variant is also known as c.2713delC. For these reasons, this variant has been classified as Pathogenic. |
Medical Genetics Unit, |
RCV001647334 | SCV004231883 | pathogenic | Mowat-Wilson syndrome | 2023-10-20 | criteria provided, single submitter | clinical testing | Heterozygous variant associated with Mowat-Wilson syndrome in at least 1 individual. ACMG/AMP criteria PVS1, PS2, PM2, PP4 |